The BioPharma sector is under constant pressure to bring more novel therapies to market, more quickly and affordably. Attaining this goal requires improved operational control and continuous real-time ...

Many cell culture experts will argue that improvements in media and feed have been more responsible than any other factor in raising production titers for therapeutic proteins. While the “nature vs.

Unlike traditional manufacturing processes in the biotechnology industry (e.g., monoclonal antibodies, gene therapies, etc.) where there are extensive downstream purification steps after the initial ...